No Data
No Data
Mydecine Announces Intention to Refile Certain Financial Statements and Applies for Management...
Mydecine Innovations Group Receives Notice of Allowance From USPTO For MYCO-005 Compound
Mydecine Innovations Group, Inc., (MYCO.CSE) on Monday said it has received the issuance of a Notice of Allowance by the United States Patent and Trademark Office (USPTO) for their MYCO-005 compound.
Canadian Securities Exchange Reports October 2023 Performance Figures
Toronto, Ontario--(Newsfile Corp. - November 17, 2023) - The Canadian Securities Exchange ("CSE" or "the Exchange") today announced market statistics for October 2023.October 2023 Operating Statistics
Mydecine Innovations Group Provided Q4 2023 Business Update
Mydecine Innovations Group, Inc., (MYCO.CSE) earlier Thursday provided a general update. The company has spent the past few months simplifying its business model, streamline workflow and processes, an
Mydecine Innovations Group Brief: Announced Admission to Trading on AQSE Growth Market in London, UK and First Day of Dealings
06:17 AM EDT, 10/10/2023 (MT Newswires) -- Mydecine Innovations Group Brief: Announced Admission to Trading on AQSE Growth Market in London, UK and First Day of Dealings